ELVN
NASDAQ · Pharmaceuticals
Enliven Therapeutics Inc
$48.62
+0.02 (+0.04%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Price Target
Analyst Price Target
-34.9% upside
Low Target
$20.91
Average Target
$31.67
High Target
$36.06
Current Price
$48.62
Current
$48.62
$48.62
Target
$31.67
$31.67
$20.91
$31.67 avg
$36.06
Scenario Analysis
Bear Case
$20.91
-57.0%
Low target
Base Case
$31.67
-34.9%
Avg target
Bull Case
$36.06
+-25.8%
High target
Risk/Reward
0.5x
Unfavorable
Price in Context
52-Week High
$48.53
0.2% from high
52-Week Low
$14.79
+228.8% from low
Target vs 52W High
$31.67
-34.7% vs high
Peer Consensus — Pharmaceuticals